WG
RVNC

Winton Group’s Revance Therapeutics, Inc. RVNC Stock Holding History

Winton Group’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10,150
Closed -$274K – 1061
2022
Q3 		$274K Buy
+10,150
New +$274K 0.02% 821
2020
Q3 		– Sell
-10,460
Closed -$255K – 1635
2020
Q2 		$255K Buy
+10,460
New +$255K 0.01% 1316